Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DX25F6STP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,247
Award facts
- Contract value 100% obligated
- $3,246.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a $3,246.51 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, reflecting the pharmaceutical products typically procured through DLA's medical supply chain to support military healthcare requirements.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's demonstrated ability to fulfill competitively awarded contracts at varying order values, combined with its expansive IDC portfolio, positions it as a primary supplier for military pharmaceutical and medical supply needs.
Quick answers
Who was awarded contract SPE2DX25F6STP?
SPE2DX25F6STP was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2DX25F6STP worth?
The government has obligated $3,247 on SPE2DX25F6STP.
Is contract SPE2DX25F6STP an order under another contract?
Yes. SPE2DX25F6STP is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6STP competed?
The extent of competition for SPE2DX25F6STP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award